President Trump has implemented and threatened expansive tariffs during his second term, causing diplomatic turmoil, market instability, and industry confusion. His shifting commitment to tariffs has led to reversals, withdrawals, and pauses, including threats of 200 percent levies on alcohol from the European Union. Actions included tariffs on Canada, Mexico, China, Colombia, and the EU, with retaliatory measures and negotiations sparking further tensions and uncertainty. The president’s back-and-forth decisions have had significant consequences on global trade relations and market dynamics.
Full Article
Medpace Beats Q2 Revenue Estimates
Medpace (NASDAQ:MEDP), a clinical contract research organization, reported strong Q2 2025 earnings, achieving GAAP revenue of $603.3 million and EPS of $3.10, surpassing estimates of $538.8 million and $2.98, respectively. The positive results led management to raise forecasts for the remainder of FY2025, reflecting ongoing operational success and top-line growth. Want More Context? 🔎
Read more